Literature DB >> 12853395

Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections.

Pei-Yun Shu1, Li-Kuang Chen, Shu-Fen Chang, Yi-Yun Yueh, Ling Chow, Li-Jung Chien, Chuan Chin, Ting-Hsiang Lin, Jyh-Hsiung Huang.   

Abstract

We have found that NS1 serotype-specific immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA) can be used to differentiate primary and secondary dengue virus infections. This is due to the fact that the NS1-specific IgG antibody cannot be detected before day 9 of illness for primary infection, so the NS1-specific IgG antibodies measured in acute-phase sera must come from previous infection. Comparison of NS1 serotype-specific IgG ELISA with envelope- and membrane-specific capture IgM and IgG ELISA in the differentiation of primary and secondary dengue virus infections showed good correlation (95.90% agreement). Most important, we have found that the serotype of the dengue virus from the majority of patients with primary infection could be correctly identified when convalescent-phase or postinfection sera were analyzed by NS1 serotype-specific IgG ELISA. These findings suggested that NS1 serotype-specific IgG ELISA could be reliably applied for serodiagnosis and seroepidemiological study of dengue virus infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853395      PMCID: PMC164246          DOI: 10.1128/cdli.10.4.622-630.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  18 in total

1.  Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.

Authors:  D H CLARKE; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1958-09       Impact factor: 2.345

2.  The Emperor's New Clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever.

Authors:  L Rosen
Journal:  Am J Trop Med Hyg       Date:  1977-05       Impact factor: 2.345

3.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

4.  Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections.

Authors:  Sophie Alcon; Antoine Talarmin; Monique Debruyne; Andrew Falconar; Vincent Deubel; Marie Flamand
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination.

Authors:  P Y Shu; L K Chen; S F Chang; Y Y Yueh; L Chow; L J Chien; C Chin; T H Lin; J H Huang
Journal:  Vaccine       Date:  2001-02-08       Impact factor: 3.641

6.  Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection.

Authors:  S B Halstead; H Shotwell; J Casals
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

7.  Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga.

Authors:  D J Gubler; D Reed; L Rosen; J R Hitchcock
Journal:  Am J Trop Med Hyg       Date:  1978-05       Impact factor: 2.345

8.  Potential application of nonstructural protein NS1 serotype-specific immunoglobulin G enzyme-linked immunosorbent assay in the seroepidemiologic study of dengue virus infection: correlation of results with those of the plaque reduction neutralization test.

Authors:  Pei-Yun Shu; Li-Kuang Chen; Shu-Fen Chang; Yi-Yun Yueh; Ling Chow; Li-Jung Chien; Chuan Chin; Hui-Hua Yang; Ting-Hsiang Lin; Jyh-Hsiung Huang
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

9.  Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with Dengue fever and Dengue hemorrhagic fever.

Authors:  P Y Shu; L K Chen; S F Chang; Y Y Yueh; L Chow; L J Chien; C Chin; T H Lin; J H Huang
Journal:  J Med Virol       Date:  2000-10       Impact factor: 2.327

10.  Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS).

Authors:  J R Bravo; M G Guzmán; G P Kouri
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

View more
  69 in total

Review 1.  Current advances in dengue diagnosis.

Authors:  Pei-Yun Shu; Jyh-Hsiung Huang
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

2.  Relationship between nonstructural protein 1 detection and plasma virus load in Dengue patients.

Authors:  Laurent Thomas; Fatiha Najioullah; Olivier Verlaeten; Jenny Martial; Ségolène Brichler; Stéphane Kaidomar; Victor Moravie; André Cabié; Raymond Césaire
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

3.  Characteristic of dengue disease in Taiwan: 2002-2007.

Authors:  Chien-Chou Lin; Yh-Hsiung Huang; Pei-Yun Shu; Ho-Sheng Wu; Yee-Shin Lin; Trai-Ming Yeh; Hsiao-Sheng Liu; Ching-Chuan Liu; Huan-Yao Lei
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

4.  Evaluation of a commercial SD dengue virus NS1 antigen capture enzyme-linked immunosorbent assay kit for early diagnosis of dengue virus infection.

Authors:  Seok Mui Wang; Shamala Devi Sekaran
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

Review 5.  Dengue: a continuing global threat.

Authors:  Maria G Guzman; Scott B Halstead; Harvey Artsob; Philippe Buchy; Jeremy Farrar; Duane J Gubler; Elizabeth Hunsperger; Axel Kroeger; Harold S Margolis; Eric Martínez; Michael B Nathan; Jose Luis Pelegrino; Cameron Simmons; Sutee Yoksan; Rosanna W Peeling
Journal:  Nat Rev Microbiol       Date:  2010-12       Impact factor: 60.633

6.  Application of the dengue virus NS1 antigen rapid test for on-site detection of imported dengue cases at airports.

Authors:  Pei-Yun Shu; Cheng-Fen Yang; Jeng-Fong Kao; Chien-Ling Su; Shu-Fen Chang; Chien-Chou Lin; Wen-Chih Yang; Hsiu Shih; Shih-Yan Yang; Ping-Fuai Wu; Ho-Sheng Wu; Jyh-Hsiung Huang
Journal:  Clin Vaccine Immunol       Date:  2009-02-04

7.  Intravenous immunoglobulin for severe thrombocytopenia in secondary dengue.

Authors:  Vinod Kumar; Kartik Gupta; Manish Soneja; Ashutosh Biswas
Journal:  BMJ Case Rep       Date:  2018-06-27

8.  Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

9.  Characteristics and Risk Factors for Fatality in Patients with Dengue Hemorrhagic Fever, Taiwan, 2014.

Authors:  Hsin-Yi Wei; Pei-Yun Shu; Min-Nan Hung
Journal:  Am J Trop Med Hyg       Date:  2016-06-06       Impact factor: 2.345

10.  Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens.

Authors:  Wayne D Crill; Holly R Hughes; Mark J Delorey; Gwong-Jen J Chang
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.